CMG Pharmaceutical Co., Ltd.
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
058820 | KO
Overview
Corporate Details
- ISIN(s):
- KR7058820002
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 학동로 170 베터라이프빌딩 3층(논현동), 강남구
- Website:
- http://www.cmgpharma.co.kr
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
CMG Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medications. As the sole pharmaceutical affiliate of CHA Health Systems, the company focuses on developing improved drugs and new formulations. A key area of its technological specialization is Oral Thin Film (OTF) pharmaceuticals, exemplified by its Tadalafil OTF product. The company's portfolio also includes prescription drugs in various forms such as tablets and capsules. CMG Pharmaceutical actively maintains a drug development pipeline and conducts clinical trials to address various therapeutic needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-11 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 17.5 KB | ||
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.6 MB | ||
| 2025-06-25 00:00 |
Share Issue/Capital Change
전환청구권행사
|
Korean | 10.3 KB | ||
| 2025-06-09 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 80.4 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.4 MB | ||
| 2025-04-30 00:00 |
Regulatory News Service
소속부변경
|
Korean | 3.6 KB | ||
| 2025-04-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 66.3 KB | ||
| 2025-04-18 00:00 |
Share Issue/Capital Change
전환청구권행사
|
Korean | 9.5 KB | ||
| 2025-04-16 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (메조피(Mezofy) 미국 식품의약국(FDA) 품목허가 획득)
|
Korean | 7.3 KB | ||
| 2025-04-15 00:00 |
Regulatory News Service
[기재정정]신규시설투자등
|
Korean | 15.7 KB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 17.2 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 659.1 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 25.0 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 6.5 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 181.1 KB |
Automate Your Workflow. Get a real-time feed of all CMG Pharmaceutical Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CMG Pharmaceutical Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CMG Pharmaceutical Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
